Evidence map›Paper›PMID 21215269›Full record

ArticleJournal of immunological methods2011

Image-based analysis of primary human neutrophil chemotaxis in an automated direct-viewing assay.

Ivar Meyvantsson, Elizabeth Vu, Casey Lamers, Daniella Echeverria, Tracy Worzella, Victoria Echeverria, Allyson Skoien, Steven Hayes

Abstract read
In one paragraph

Article in Journal of immunological methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  6. Review
  7. On a chip.IEEE pulse · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ivar MeyvantssonBellbrook Labs, 5500 Nobel Dr., Ste. 250, Madison, WI 53711, USA. ivar.meyvantsson@bellbrooklabs.com
Elizabeth Vu
Casey Lamers
Daniella Echeverria
Tracy Worzella
Victoria Echeverria
Allyson Skoien
Steven Hayes

Funding

A microfluidic chemotaxis device for high content screeningR44HL088785 · NHLBI · BELLBROOK LABS, LLC · PI MEYVANTSSON, IVAR · 2009 to 2010
$963k
A Microfluidic Chemotaxis High Throughput SystemR43HL088785 · NHLBI · BELLBROOK LABS, LLC · PI MEYVANTSSON, IVAR · 2007 to 2007
$302k
NHLBI NIH HHS HL088785NHLBI NIH HHS R43 HL088785NHLBI NIH HHS R44 HL088785
6 · The paper itself

Abstract

Multi-well assays based on the Boyden chamber have enabled highly parallel studies of chemotaxis-the directional migration of cells in response to molecular gradients-while direct-viewing approaches have allowed more detailed questions to be asked at low throughput. Boyden-based plates provide a count of cells that pass through a membrane, but no information about cell appearance. In contrast, direct-viewing devices enable the observation of cells during chemotaxis, which allows measurement of many parameters including area, shape, and location. Here we show automated chemotaxis and cell morphology assays in a 96-unit direct-viewing plate. Using only 12000 primary human neutrophils per datum, we measured dose-dependent stimulation and inhibition of chemotaxis and quantified the effects of inhibitors on cell area and elongation. With 60 parallel conditions we demonstrated 5-fold increase in throughput compared to previously reported direct-viewing approaches.

Indexed as

Immunologic TechniquesChemotaxis, LeukocyteEquipment DesignHumansInterleukin-8Microfluidic Analytical TechniquesNeutrophilsRecombinant ProteinsCXCL8 protein, humanInterleukin-8Recombinant Proteins

Identifiers

PMID21215269
PMCPMC3094597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.